secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001683168-26-003381
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals prices $4.0M public offering of units at $1.35/unit
--------------------------------------------------------------------------

- Offering of 2,962,962 units initially, each unit one share (or pre-funded warrant) and one warrant at $1.35 per unit.
- Total gross proceeds ~$4.0M; net proceeds ~$3.5M after underwriting discount and expenses.
- Closing occurred April 27-28, 2026 with full over-allotment exercise; 1,650,716 common shares, 1,312,247 pre-funded warrants, 3,407,404 warrants issued.
- Warrants exercisable at $1.35 per share for five years; Underwriters' warrants for 5% of sold securities at 110% of offering price.
- Net proceeds to be used for general corporate purposes including working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826003381/0001683168-26-003381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826003381/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-003381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer